| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Assessment of current virotherapeutic application schemes: “hit hard and early” versus “killing softly”?
|
Ruf, Benjamin
|
|
2015
|
2 |
C |
p. -
1 p.
|
artikel
|
| 2 |
ATN-224 enhances antitumor efficacy of oncolytic herpes virus against both local and metastatic head and neck squamous cell carcinoma
|
Yoo, Ji Young
|
|
2015
|
2 |
C |
p. -
1 p.
|
artikel
|
| 3 |
Chimeric antigen receptor–engineered T cells as oncolytic virus carriers
|
VanSeggelen, Heather
|
|
2015
|
2 |
C |
p. -
1 p.
|
artikel
|
| 4 |
Combination of the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus as a new option for epi-virotherapeutic treatment of hepatocellular carcinoma
|
Ruf, Benjamin
|
|
2015
|
2 |
C |
p. -
1 p.
|
artikel
|
| 5 |
Designing herpes viruses as oncolytics
|
Peters, Cole
|
|
2015
|
2 |
C |
p. -
1 p.
|
artikel
|
| 6 |
Enhanced efficacy with azacytidine and oncolytic BHV-1 in a tolerized cotton rat model of breast adenocarcinoma
|
Cuddington, Breanne P
|
|
2015
|
2 |
C |
p. -
1 p.
|
artikel
|
| 7 |
Evidence for differential viral oncolytic efficacy in an in vitro model of epithelial ovarian cancer metastasis
|
Tong, Jessica G
|
|
2015
|
2 |
C |
p. -
1 p.
|
artikel
|
| 8 |
Expression of anti-VEGF antibody together with anti-EGFR or anti-FAP enhances tumor regression as a result of vaccinia virotherapy
|
Huang, Ting
|
|
2015
|
2 |
C |
p. -
1 p.
|
artikel
|
| 9 |
Inhibition of hypoxia-inducible factor via upregulation of von Hippel-Lindau protein induces “angiogenic switch off” in a hepatoma mouse model
|
Iwamoto, Hideki
|
|
2015
|
2 |
C |
p. -
1 p.
|
artikel
|
| 10 |
Intratumoral INF-γ triggers an antiviral state in GL261 tumor cells: a major hurdle to overcome for oncolytic vaccinia virus therapy of cancer
|
Kober, Christina
|
|
2015
|
2 |
C |
p. -
1 p.
|
artikel
|
| 11 |
L-Asparaginase delivered by Salmonella typhimurium suppresses solid tumors
|
Kim, Kwangsoo
|
|
2015
|
2 |
C |
p. -
1 p.
|
artikel
|
| 12 |
Oncolysis by paramyxoviruses: multiple mechanisms contribute to therapeutic efficiency
|
Matveeva, Olga V
|
|
2015
|
2 |
C |
p. -
1 p.
|
artikel
|
| 13 |
Oncolysis by paramyxoviruses: preclinical and clinical studies
|
Matveeva, Olga V
|
|
2015
|
2 |
C |
p. -
1 p.
|
artikel
|
| 14 |
Oncolytic potency of HER-2 retargeted VSV-FH hybrid viruses: the role of receptor ligand affinity
|
Ayala Breton, Camilo
|
|
2015
|
2 |
C |
p. -
1 p.
|
artikel
|
| 15 |
Pediatric cancer gone viral. Part II: potential clinical application of oncolytic herpes simplex virus-1 in children
|
Friedman, Gregory K
|
|
2015
|
2 |
C |
p. -
1 p.
|
artikel
|
| 16 |
Pediatric cancer gone viral. Part I: strategies for utilizing oncolytic herpes simplex virus-1 in children
|
Cripe, Timothy P
|
|
2015
|
2 |
C |
p. -
1 p.
|
artikel
|
| 17 |
Preclinical toxicology of oncolytic adenovirus-mediated cytotoxic and interleukin-12 gene therapy for prostate cancer
|
Freytag, Svend O
|
|
2015
|
2 |
C |
p. -
1 p.
|
artikel
|
| 18 |
Retargeted oncolytic adenovirus displaying a single variable domain of camelid heavy-chain-only antibody in a fiber protein
|
van Erp, Elisabeth A
|
|
2015
|
2 |
C |
p. -
1 p.
|
artikel
|
Tijdschrift beschrijving